🔗 Permalink

Inventor profile of:

Mark KEATING

City:

Weston, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2026-06-18

Top Assignees for applications by Mark KEATING

The entities that hold a legal rights for patent applications filed by inventor KEATING Mark:

ALNYLAM PHARMACEUTICALS, INC. 6 Cambridge, MA United States
NOVARTIS AG 1 Basel, Switzerland

Recent patent applications by KEATING Mark

Mark KEATING from Weston, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-06-18

US20260167961A1

Chemistry; metallurgy

TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED OCULAR DISEASES

#2 | 2026-02-19

US20260049312A1

Chemistry; metallurgy

COMPLEMENT COMPONENT C3 IRNA COMPOSITIONS AND METHODS OF USE THEREOF

#3 | 2024-07-04

US20240218366A1

Chemistry; metallurgy

COAGULATION FACTOR V (F5) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

#4 | 2024-06-27

US20240209369A1

Chemistry; metallurgy

Complement component C3 iRNA compositions and methods of use thereof

#5 | 2024-06-27

US20240209358A1

Chemistry; metallurgy

COAGULATION FACTOR V (F5) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

#6 | 2024-06-20

US20240200061A1

Chemistry; metallurgy

TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED OCULAR DISEASES

#7 | 2024-04-11

US20240117348A1

Chemistry; metallurgy

COAGULATION FACTOR X (F10) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

#8 | 2023-09-28

US20230304002A1

Chemistry; metallurgy

TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED OCULAR DISEASES

#9 | 2023-09-21

US20230295622A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR SILENCING MYOC EXPRESSION

#10 | 2023-08-31

US20230272382A1

Chemistry; metallurgy

COMPLEMENT COMPONENT C3 iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING COMPLEMENT COMPONENT C3-ASSOCIATED DISEASES

#11 | 2023-05-04

US20230136787A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR SILENCING VEGF-A EXPRESSION

#12 | 2022-11-17

US20220364088A1

Chemistry; metallurgy

COMPLEMENT COMPONENT C3 IRNA COMPOSITIONS AND METHODS OF USE THEREOF

#13 | 2022-10-20

US20220333104A1

Chemistry; metallurgy

TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED OCULAR DISEASES

#14 | 2021-09-16

US20210283262A1

Human necessities

mRNA-mediated immunization methods

InventorID:

5187822 ⎘